Cargando…

Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington’s Patients

Oxidative stress has long been implicated in the pathophysiology and progression of Huntington’s disease (HD). Uric acid (UA) is a naturally occurring antioxidant that is present in the brain and periphery. Growing evidence has implicated UA as a molecular biomarker for several neurodegenerative dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corey-Bloom, Jody, Haque, Ameera, Aboufadel, Sameer, Snell, Chase, Fischer, Ryan S., Granger, Steven W., Granger, Douglas A., Thomas, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065265/ https://www.ncbi.nlm.nih.gov/pubmed/32194366 http://dx.doi.org/10.3389/fnins.2020.00073

Ejemplares similares

Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington’s Disease Patients and Healthy Control Subjects
por: Corey-Bloom, Jody, et al.
Publicado: (2020)

Development and Psychometric Properties of a New Brief, Yet Comprehensive, Behavioral Questionnaire for Huntington's Disease
por: Hughes, Shelby, et al.
Publicado: (2023)

Salivary Huntingtin protein is uniquely associated with clinical features of Huntington’s disease
por: Parkin, Georgia M., et al.
Publicado: (2023)

Salivary levels of total huntingtin are elevated in Huntington’s disease patients
por: Corey-Bloom, Jody, et al.
Publicado: (2018)

Plasma neurofilament light in Huntington’s disease: A marker for disease onset, but not symptom progression
por: Parkin, Georgia M., et al.
Publicado: (2021)

Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients
por: Gutierrez, Ashley, et al.
Publicado: (2020)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Characterizing and Evaluating Diurnal Salivary Uric Acid Across Pregnancy Among Healthy Women
por: Riis, Jenna L., et al.
Publicado: (2022)

Assessing the state of care for Huntington disease in the United States: Results from a survey of practices treating Huntington disease patients
por: Seeberger, Lauren, et al.
Publicado: (2022)

Salivary uric acid across child development and associations with weight, height, and body mass index
por: Riis, J. L., et al.
Publicado: (2023)

What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
por: Przybyl, Lukasz, et al.
Publicado: (2021)

Discovering Wavelets
por: Aboufadel, Edward, et al.
Publicado: (1999)

Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
por: Reyes, Alvaro, et al.
Publicado: (2018)

Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood
por: Mastrokolias, Anastasios, et al.
Publicado: (2015)

Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease
por: Claassen, Daniel O., et al.
Publicado: (2020)

LASSI-L detects early cognitive changes in pre-motor manifest Huntington’s disease: a replication and validation study
por: Sierra, Luis A., et al.
Publicado: (2023)

Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional study
por: Parkin, Georgia M., et al.
Publicado: (2023)

Abnormal peripheral chemokine profile in Huntington’s disease
por: Wild, Edward, et al.
Publicado: (2011)

Dispatches from the Interface of Salivary Bioscience and Neonatal Research
por: Voegtline, Kristin M., et al.
Publicado: (2014)

Correspondence Between Cytomegalovirus Immunoglobulin-G Levels Measured in Saliva and Serum
por: Riis, Jenna L., et al.
Publicado: (2020)

Leishman-Donovan Infection in a Gurkha
por: Granger, T. A.
Publicado: (1907)

Serum uric acid a depression biomarker
por: Meng, Xiandong, et al.
Publicado: (2020)

Functional Impairment of Skin Appendages Due to Peripheral Nerve Involvement by Mycobacterium leprae
por: Granger, Donald L, et al.
Publicado: (2020)

A Glimpse of Molecular Biomarkers in Huntington’s Disease
por: Martí-Martínez, Silvia, et al.
Publicado: (2022)

Clinical and genetic features of Huntington disease in Sri Lanka
por: Sumathipala, Dulika S, et al.
Publicado: (2013)

Targeting Tau to Treat Clinical Features of Huntington's Disease
por: Masnata, Maria, et al.
Publicado: (2020)

Household fear of deportation in relation to chronic stressors and salivary proinflammatory cytokines in Mexican-origin families post-SB 1070
por: Martínez, Airín D., et al.
Publicado: (2018)

Blast-Induced Neurotrauma Results in Spatially Distinct Gray Matter Alteration Alongside Hormonal Alteration: A Preliminary Investigation
por: Hellewell, Sarah C., et al.
Publicado: (2023)

Lamin B1 and nuclear morphology in peripheral cells as new potential biomarkers to follow treatment response in Huntington's disease
por: Garcia‐Forn, Marta, et al.
Publicado: (2023)

A case series of 15 patients with oesophageal cancer in Blantyre, Malawi. Risk factors for oesophageal squamous cell carcinoma in Sub-Saharan Africa
por: Granger, S
Publicado: (2012)

The Design of a Low Noise, Multi-Channel Recording System for Use in Implanted Peripheral Nerve Interfaces
por: Sadrafshari, Shamin, et al.
Publicado: (2022)

Fluid mechanics
por: Granger, Robert A.
Publicado: (1995)

From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
por: Jiang, Andrew, et al.
Publicado: (2023)

Uncovering the Genetic and Molecular Features of Huntington’s Disease in Northern Colombia
por: Ahmad, Mostapha, et al.
Publicado: (2023)

Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis
por: Pagkopoulou, Eleni, et al.
Publicado: (2021)

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children
por: Byrne, Lauren M., et al.
Publicado: (2022)

The updated development of blood-based biomarkers for Huntington’s disease
por: Zhang, Sirui, et al.
Publicado: (2023)

Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023)

Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington’s disease monkeys
por: Kocerha, Jannet, et al.
Publicado: (2013)

A Computational Cognitive Biomarker for Early-Stage Huntington’s Disease
por: Wiecki, Thomas V., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eqeg31ig91rmkgatjfrgenbi6t